Argent Biopharma Limited has released a press release.
Mgc pharma delivers record consecutive weekly sales growth
Filed with ASX · · 3 pages · English
6ix is checking which company filed this.
Earlier from Argent Biopharma
- ArtemiC histology on rats confirm no pathological impact
- First high THC products shipped direct to Brazil patients
- MGC pharma launches CannEpil app
- Update on ArtemiC phase II trial on COVID-19 patients
- Mxc welcomes new FCA guidance for cannabis sector in the UK
Later from Argent Biopharma
- September Quarterly Activity and Cashflow Report
- Completion of phase II clinical trial on COVID-19 patients
- Further successful results from glioblastoma research
- MGC pharma completes acquisition of telehealth platform MCC
- Prospectus
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma